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Background
Milk oral immunotherapy (MOIT) may be an alternative
to avoidance in treatment of patients with IgE-mediated
cow milk allergy (IMCMA). We aim to determine the
effect of MIOT through a systematic review.
Methods
Randomized controlled trials on MOIT were identified
from 13 databases, conference proceedings, theses and
unpublished trials, as part of a review with the Cochrane
Collaboration. A total 1945 records were identified
and screened. Children and adults with IMCMA were
included. Studies were selected and methodological quality
assessed independently by two reviewers.
Results
138 records were reviewed and 13 were included, repre-
senting 4 trials. A total of 170 patients were studied (88
MOIT, 82 control). Two studies used blinding and 2 used
an avoidance diet control. Fifty-two (59%) patients of the
MOIT group were able to tolerate a full serving of milk
(about 200mL) compared to 7 (9%) of the control group
(RR 6.05, 95% CI 3.2, 11.44). In addition, 26 (30%) in the
MOIT group could ingest a partial serving of milk (10-
184mL) while none could in the control group (RR 11.55,
95% CI 2.85, 46.87). None of the studies assessed the
patients following a period off immunotherapy. Adverse
reactions were common (79 of 88 had at least one symp-
tom), although most were local and mild. For every 7
patients receiving MOIT, 1 required intramuscular epi-
nephrine. One patient required it on 2 occasions.
Conclusion
MOIT can lead to desensitization in the majority of
individuals with IMCMA although the development of
long-term tolerance has not been established.
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